Journal article
Use of co-primary outcomes for trials of antimicrobial stewardship interventions
- Abstract:
- Antimicrobial resistance (AMR) is a major public health threat that will cause an estimated 10 million deaths worldwide by 2050. Because antimicrobial use drives selection and transmission of AMR, there is an urgent need to continue to develop, evaluate, and implement effective, evidence-based antimicrobial stewardship (AMS) interventions that safely reduce antimicrobial use in both primary and secondary healthcare.
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 277.0KB, Terms of use)
-
- Publisher copy:
- 10.1016/s1473-3099(18)30289-5
Authors
- Publisher:
- Elsevier
- Journal:
- Lancet Infectious Diseases More from this journal
- Volume:
- 18
- Issue:
- 6
- Pages:
- 595-597
- Publication date:
- 2018-05-24
- Acceptance date:
- 2018-05-15
- DOI:
- EISSN:
-
1474-4457
- ISSN:
-
1473-3099
- Pmid:
-
29856347
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:854729
- UUID:
-
uuid:20a4735f-fad8-4284-b3b3-df14740a12ba
- Local pid:
-
pubs:854729
- Source identifiers:
-
854729
- Deposit date:
-
2018-06-25
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2018
- Notes:
- © 2018 Elsevier Ltd. All rights reserved. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/S1473-3099(18)30289-5
If you are the owner of this record, you can report an update to it here: Report update to this record